Jasper Therapeutics(us:JSPR)

    21.57

    +0.19%

    Updated on 2024-12-22

    Open:21.12
    Close:21.57
    High:22.20
    Low:21.00
    Pre Close:21.53
    Volume:212530.00
    Amount:4.59M
    Turnover:1.42%
    Shares:15.00M
    MarketCap:323.58M

    About Jasper Therapeutics Company

    Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.

    Company Name: Jasper Therapeutics
    Company Address: 2200 Bridge Parkway,Suite 102
    Employees: 45
    Fiscar Year: 12-31
    IPO Date: 2020-01-10
    CIK: 1788028

    View all SEC Filings

    About

    Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
    Address:2200 Bridge Parkway,Suite 102
    Website:http://www.jaspertherapeutics.com

    Market Movers